{"filings":[{"id":1195156,"accession_number":"0001074828-26-000037","cik":1074828,"company_name":"USBC, Inc.","ticker":"USBC","form_type":"8-K","filed_at":"2026-06-22T20:15:00+00:00","items":["5.07","8.01","9.01"],"status":"ready","headline":"USBC approves reverse stock split 1:2 to 1:5; tokenized deposit product testing advances","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Majority holder Goldeneye 1995 LLC (92.2% voting power) approved reverse split via written consent on June 15, 2026.","Reverse split ratio range 1-for-2 to 1-for-5; board approved June 12, 2026; effective within 12 months of approval.","Company completed initial technical testing of USBC tokenized deposit product with limited internal users.","Development costs accelerating; company expects to issue additional common shares to fund future capital needs.","Reverse split intended to improve stock marketability for capital raising; no guarantee of achieving objectives."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":173030000.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":844478,"accession_number":"0001074828-26-000030","cik":1074828,"company_name":"USBC, Inc.","ticker":"USBC","form_type":"8-K","filed_at":"2026-06-04T13:15:02+00:00","items":["2.03","8.01","9.01"],"status":"ready","headline":"USBC tokenized deposit testing advances; $3.9M spent; additional $5M Bitcoin loan drawn","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Drew $5M under Master Loan Agreement with Payward Interactive, total outstanding $15M at 8.5%, matures June 1, 2027, secured by Bitcoin.","Tokenized deposit product testing completed for core features (ACH funding, spending, treasury conversion); limited market testing planned.","Development costs accelerating; $3.9M reimbursed to Vast Bank under $10.5M cap as of May 31, 2026.","Collateral coverage would hit 130% margin call on ~13% Bitcoin price drop; no calls or liquidations as of June 3, 2026."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":173030000.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":91109,"accession_number":"0001074828-26-000023","cik":1074828,"company_name":"USBC, Inc.","ticker":"USBC","form_type":"8-K","filed_at":"2026-05-01T23:59:59+00:00","items":["2.03","8.01","9.01"],"status":"ready","headline":"USBC draws $5M under MLA (total $10M); tokenized deposit Phase 1 testing ongoing","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["USBC drew additional $5M under existing Master Loan Agreement with Payward Interactive, increasing total borrowings to $10M.","Loan carries 8.5% interest, matures April 27, 2027, secured by Bitcoin collateral held at Payward Financial.","Phase 1 tokenized deposit testing ongoing; development costs accelerating, $3.5M reimbursed to Vast Holdings under $10.5M cap.","Results from Phase 1 will inform timing of subsequent phases and potential retail product launch."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":173030000.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":91108,"accession_number":"0001074828-26-000008","cik":1074828,"company_name":"USBC, Inc.","ticker":"USBC","form_type":"8-K","filed_at":"2026-04-15T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Ronald P. Erickson departs USBC as director and Science Division President; receives severance","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Erickson's service concluded March 27, 2026, following divestiture of legacy sensor business.","Separation Agreement provides severance of $375,000 annual base salary over one year.","All 167,500 unvested Restricted Shares accelerated and vested upon his last employment date.","Erickson eligible for separation benefits per employment agreement dated August 6, 2025.","Departure not due to any disagreement with the company or its affiliates."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":173030000.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":91107,"accession_number":"0001171843-26-002209","cik":1074828,"company_name":"USBC, Inc.","ticker":"USBC","form_type":"8-K","filed_at":"2026-04-02T23:59:59+00:00","items":["1.01","2.03","5.02","7.01","9.01"],"status":"ready","headline":"USBC sells legacy sensor business for $1, retains 10% revenue share; provides $450k loan","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Divested non-invasive sensor tech business for $1 plus 10% revenue share on future Covered Products.","Provided short-term secured promissory note of up to $450,000 to buyer for operating expenses.","Ronald Erickson departed as director and President of Science Division effective March 27, 2026.","Company refocuses on tokenized deposit fintech initiative; retains economic interest in sensor tech.","Divestiture approved by independent Audit Committee; financial impact not expected to be material."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":173030000.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":101027,"accession_number":"0001171843-26-002066","cik":1074828,"company_name":"USBC, Inc.","ticker":"USBC","form_type":"8-K","filed_at":"2026-03-31T23:59:59+00:00","items":["3.01","7.01","9.01"],"status":"ready","headline":"USBC regains NYSE American listing compliance; delisting risk resolved","summary_kind":"llm","event_type":"regulatory","confidence":"high","bullets":["NYSE American notified USBC on March 27, 2026 of full compliance with continued listing standards.","Previously noncompliant on minimum stockholders' equity since September 2024.","Compliance regained via capital from Goldeneye 1995 LLC acquisition in August 2025.","\".BC\" indicator removed; company removed from noncompliant issuer list.","Company remains subject to ongoing listing standards and monitoring."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":173030000.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":101026,"accession_number":"0001074828-26-000005","cik":1074828,"company_name":"USBC, Inc.","ticker":"USBC","form_type":"8-K","filed_at":"2026-03-24T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"USBC reprices 83M outstanding stock options to $0.37; includes CFO and Vice Chair holdings","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Board approved repricing of all 83.0 million outstanding options to $0.37 per share (closing price on March 18, 2026).","CFO Kitty Payne had 3,750,000 options repriced; Director/Vice Chair Linda Jenkinson had 10,000,000 options repriced.","Repricing effective March 18, 2026; intended to motivate and retain optionees.","Options were repriced under the Amended and Restated 2021 Equity Incentive Plan."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":173030000.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":101025,"accession_number":"0001171843-26-001453","cik":1074828,"company_name":"USBC, Inc.","ticker":"USBC","form_type":"8-K","filed_at":"2026-03-10T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"USBC initiates Phase 1 internal employee pilot for tokenized deposit offering","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Phase 1 launched with limited internal users for technical readiness testing in non-production environment.","Pilot is not a consumer offering and is not available to the public at this time.","Retail launch timing depends on Phase 1 results, regulatory, board, and bank partner approvals.","No financial impact or specific launch date disclosed; forward-looking statements caution on risks."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"market_cap_usd":173030000.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":101024,"accession_number":"0001654954-26-000601","cik":1074828,"company_name":"USBC, Inc.","ticker":"USBC","form_type":"8-K","filed_at":"2026-01-26T23:59:59+00:00","items":["1.01","7.01","9.01"],"status":"ready","headline":"USBC signs definitive triparty agreement with Uphold and Vast Bank for tokenized deposits","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Agreement dated Jan 20, 2026; press release Jan 26, 2026.","Uphold becomes exclusive partner for tokenized deposits at launch; USBC/Vast Bank exclusivity on market maker.","Initial term one year from general launch, auto-renewing; replaces Oct 2025 MOU.","Parties target use cases: faster settlement, treasury ops, digital asset services, subject to regulatory approvals."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":173030000.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":101022,"accession_number":"0001654954-26-000281","cik":1074828,"company_name":"USBC, Inc.","ticker":"USBC","form_type":"8-K/A","filed_at":"2026-01-13T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"USBC COO Kirk Chapman departs; separation agreement includes $320k severance","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Kirk Chapman, COO, mutually agreed to leave effective Dec 15, 2025; he joined the Company in Aug 2025.","Severance: $320k annual base salary paid regularly until Dec 31, 2026 or start of other employment.","Non-compete waived; unvested options forfeited; standard release and non-disparagement."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":173030000.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":101023,"accession_number":"0001654954-26-000275","cik":1074828,"company_name":"USBC, Inc.","ticker":"USBC","form_type":"8-K","filed_at":"2026-01-12T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"USBC COO Kirk Chapman departs; separation agreement provides $320K salary severance through Dec 2026","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["COO Kirk Chapman departed effective Dec 15, 2025; separation agreement signed Jan 6, 2026.","Mr. Chapman receives severance equal to annual base salary of $320,000 payable until Dec 31, 2026 or earlier if he obtains other employment.","All unvested option awards forfeited as of Dec 31, 2025.","Company waives post-employment non-competition; customary release and non-disparagement remain."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":173030000.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":117366,"accession_number":"0001161697-25-000473","cik":1074828,"company_name":"USBC, Inc.","ticker":"USBC","form_type":"8-K","filed_at":"2025-12-19T23:59:59+00:00","items":["1.01","9.01"],"status":"ready","headline":"USBC amends digital asset management agreement for Bitcoin treasury strategy","summary_kind":"llm","event_type":"other_material","confidence":"low","bullets":["USBC entered an amended and restated Digital Asset Management Agreement with Hyrcanian Asset Management on December 12, 2025.","The amendment updates and clarifies terms for discretionary treasury management of USBC's Bitcoin holdings.","No specific financial terms, fee changes, or Bitcoin amounts were disclosed in the filing.","The agreement was filed as an exhibit but the full terms are not summarized in the 8-K text."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"market_cap_usd":173030000.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":117365,"accession_number":"0001161697-25-000467","cik":1074828,"company_name":"USBC, Inc.","ticker":"USBC","form_type":"8-K","filed_at":"2025-12-17T23:59:59+00:00","items":["5.02","5.03","9.01"],"status":"ready","headline":"USBC COO Kirk Chapman departs; Series C/D/H preferred stock designations withdrawn","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Kirk Chapman mutually agreed to step down as COO effective Dec 15, 2025; departure not due to any disagreement.","Company terminated designations for Series C, D, and H Convertible Preferred Stock; no shares were outstanding.","Certificates of withdrawal filed with Nevada Secretary of State on Dec 11, 2025; provisions deleted from articles."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.45,"calibrated_materiality_score":0.45,"market_cap_usd":173030000.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":117364,"accession_number":"0001161697-25-000380","cik":1074828,"company_name":"USBC, Inc.","ticker":"USBC","form_type":"8-K","filed_at":"2025-11-21T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"USBC board member John Cronin resigns effective Nov 19, 2025","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["John Cronin resigned from the USBC Board of Directors on November 19, 2025.","Resignation not due to any disagreement with the Company or its management.","No replacement director named in the filing.","Resignation effective immediately as of November 19, 2025."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":173030000.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":117363,"accession_number":"0001161697-25-000354","cik":1074828,"company_name":"USBC, Inc.","ticker":"USBC","form_type":"8-K","filed_at":"2025-10-08T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"USBC reprices 48.6M options to $1.10, grants 55M new options to execs","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Board repriced 48,620,000 outstanding options from $2.45 to $1.10 per share on Oct 7.","Granted 55,030,000 new ten-year options at $1.10, vesting over four years.","CFO Kitty Payne had 1,790,000 options repriced and received 1,960,000 new options.","COO Kirk Chapman had 7,140,000 options repriced and received 7,860,000 new options.","Director Linda Jenkinson had 4,760,000 options repriced and received 5,240,000 new options."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":173030000.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":117362,"accession_number":"0001654954-25-011446","cik":1074828,"company_name":"USBC, Inc.","ticker":"USBC","form_type":"8-K","filed_at":"2025-10-03T23:59:59+00:00","items":["5.02","5.07","9.01"],"status":"ready","headline":"USBC shareholders approve amended 2021 equity plan, adding 65M shares","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Plan approved with 362.7M for vs. 2.4M against; authorized shares increased by 65M to 115M plus evergreen.","Amended plan permits repricings and exchanges of awards; evergreen provision set at up to 15M shares/year through 2030.","Eight directors re-elected with >364M votes each; BPM LLP ratified as auditor for FY2025 with 368M votes.","Annual meeting held Sept 29, 2025; 95.83% of outstanding shares represented."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":173030000.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":133792,"accession_number":"0001654954-25-010447","cik":1074828,"company_name":"USBC, Inc.","ticker":"USBC","form_type":"8-K","filed_at":"2025-09-05T23:59:59+00:00","items":["1.01","9.01"],"status":"ready","headline":"USBC ups ATM offering capacity from $5M to $14.5M; raised $1.27M since Dec 2024","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Increased maximum offering under Capital on Demand Sales Agreement with JonesTrading to $14.5 million.","Since Dec 31, 2024, sold 1,708,124 shares for gross proceeds of ~$1,269,236.","Outstanding common shares as of Sep 4, 2025: 384,234,130.","Proceeds to be used for general corporate purposes, including working capital and capex.","No minimum offering amount; total shares and proceeds not determinable."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":173030000.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":133791,"accession_number":"0001654954-25-009690","cik":1074828,"company_name":"USBC, Inc.","ticker":"USBC","form_type":"8-K","filed_at":"2025-08-15T23:59:59+00:00","items":["5.02","8.01","9.01"],"status":"ready","headline":"USBC completes name/ticker change to USBC after $125M acquisition by Goldeneye 1995 LLC","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Name changed from Know Labs to USBC, Inc.; ticker changed to USBC on NYSE American, effective Aug 15, 2025.","Acquisition of controlling interest by Goldeneye 1995 LLC for $125M closed Aug 6, 2025; Greg Kidd remains Chairman and CEO.","Company adopted indemnification agreements for all directors and officers; principal executive offices moved to Reno, NV."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":173030000.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":133790,"accession_number":"0001654954-25-009164","cik":1074828,"company_name":"USBC, Inc.","ticker":"USBC","form_type":"8-K","filed_at":"2025-08-07T23:59:59+00:00","items":["1.01","1.02","3.02","8.01","5.01","5.02","5.03","9.01"],"status":"ready","headline":"Know Labs sells ~81% control for 1,000 Bitcoin & $15M; new CEO, CFO, COO assume roles","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Goldeneye 1995 LLC (Robert Kidd) acquired ~81% of Know Labs common stock on a fully diluted basis for 1,000 Bitcoin + $15M cash.","New Bitcoin treasury strategy; entered Digital Asset Management Agreement with Hyrcanian, 1% annual management fee and 25% performance fee payable in Bitcoin.","Robert Gregory Kidd appointed CEO, Chairman; Kitty Payne CFO; Kirk Chapman COO; Linda Jenkinson Vice Chair of board.","Prior CEO Ronald Erickson transitions to President of Science Division, Senior VP; Peter Conley's employment terminated with 12 months severance.","Company terminated existing debt: repaid Lind $2.35M, Struve $75K and converted ~3M shares, plus repurchased preferred stock."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":1.0,"calibrated_materiality_score":1.0,"market_cap_usd":173030000.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":133789,"accession_number":"0001654954-25-008797","cik":1074828,"company_name":"USBC, Inc.","ticker":"USBC","form_type":"8-K","filed_at":"2025-08-01T23:59:59+00:00","items":["5.02","5.03","5.07","9.01"],"status":"ready","headline":"Know Labs shareholders approve 100x increase in authorized shares and private placement with change of control","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Authorized common shares increased from 7.5M to 750M (approved 5,036,628 For, 329,796 Against).","Private placement with Goldeneye 1995 LLC for >19.99% of shares and change of control approved (5,085,670 For, 266,619 Against).","2021 Equity Incentive Plan amended to add 48,950,000 shares; total pool now 50M shares (4,777,847 For, 582,030 Against).","Special Meeting adjourned from July 24 to July 31, 2025; quorum achieved with 56.18% of Company Stock represented.","All four proposals passed: authorized shares increase, private placement, plan amendment, and adjournment authority."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.9,"calibrated_materiality_score":0.9,"market_cap_usd":173030000.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":133788,"accession_number":"0001654954-25-008656","cik":1074828,"company_name":"USBC, Inc.","ticker":"USBC","form_type":"8-K","filed_at":"2025-07-30T23:59:59+00:00","items":["1.01","2.03","9.01"],"status":"ready","headline":"Know Labs enters bridge loan agreement for up to $350,000 with Goldeneye 1995 LLC","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Initial term loan of $90,000 funded on July 28, 2025; additional loans up to $260,000 at lender's discretion.","Bridge loan accrues interest at 12% per annum; maturity on the earlier of Jan 28, 2026 or demand by lender.","Proceeds intended to bridge to a previously announced private placement of common stock.","Event of default triggers acceleration of all principal and accrued interest; default includes non-payment or bankruptcy."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":173030000.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":150523,"accession_number":"0001654954-25-006660","cik":1074828,"company_name":"USBC, Inc.","ticker":"USBC","form_type":"8-K","filed_at":"2025-06-06T23:59:59+00:00","items":["1.01","3.02","5.02","7.01","9.01"],"status":"ready","headline":"Greg Kidd affiliate to acquire controlling interest in Know Labs with Bitcoin treasury strategy","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Buyer to pay 1,000 Bitcoin + $12M-$15M cash for shares at $0.335/share, achieving controlling interest.","Bitcoin will become principal balance sheet asset; management will use mNAV metric to measure premium/discount.","Greg Kidd to become CEO and Chairman; Ron Erickson becomes Vice Chairman and President of diagnostics division.","Closing expected Q3 2025, subject to shareholder approval; ~37% voting power already committed via support agreements.","Implied entry mNAV 1.22x, Bitcoin 82% of $128M market cap (assumes $105K/BTC)."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":173030000.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":150522,"accession_number":"0001654954-25-006583","cik":1074828,"company_name":"USBC, Inc.","ticker":"USBC","form_type":"8-K","filed_at":"2025-06-04T23:59:59+00:00","items":["1.01","5.03","3.02","3.03","9.01"],"status":"ready","headline":"Know Labs issues 16,916 Series H preferred shares to CEO affiliate in $1.18M debt conversion","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Converted $1,184,066 in insider debt into 16,916 shares of Series H Convertible Preferred Stock.","Series H has $70 stated value, 8% cumulative dividend; convertible into common at $0.335/share, subject to 19.99% ownership cap.","Conversion allowed after Sept 30, 2025; shares rank senior to common and junior to Series C and D preferred.","Issued unregistered under Section 4(a)(2) to an accredited investor (J3E2A2Z LP, affiliated with CEO Ronald Erickson)."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":173030000.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":169486,"accession_number":"0001654954-25-002090","cik":1074828,"company_name":"USBC, Inc.","ticker":"USBC","form_type":"8-K","filed_at":"2025-02-28T23:59:59+00:00","items":["3.01","7.01","9.01"],"status":"ready","headline":"NYSE lifts trading suspension for Know Labs; stock resumes March 5, 2025","summary_kind":"llm","event_type":"regulatory","confidence":"high","bullets":["Trading suspension lifted after stock price exceeded NYSE American low-selling-price threshold.","Common stock to resume trading on NYSE American on March 5, 2025, under symbol KNW.","Company remains subject to compliance plan for continued listing standards (Sections 1003(a)(i)-(iii)), with target completion by March 27, 2026.","NYSE American accepted the plan on December 10, 2024; failure to meet requirements may restart delisting proceedings."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":173030000.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":169485,"accession_number":"0001654954-25-001992","cik":1074828,"company_name":"USBC, Inc.","ticker":"USBC","form_type":"8-K","filed_at":"2025-02-27T23:59:59+00:00","items":["7.01","8.01","9.01"],"status":"ready","headline":"Know Labs approved to trade on OTCQB Venture Market under symbol KNWN","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Common shares approved for OTCQB quotation effective open of trading February 26, 2025.","Ticker symbol changed to KNWN; previously had temporary \"D\" due to reverse stock split.","OTCQB requires current financial reporting, minimum bid price, and annual certification.","Upgrade expected to provide increased transparency, market depth disclosure, and liquidity.","Know Labs specializes in Radio Frequency Dielectric Spectroscopy (RFDS) sensor technology."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":173030000.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":169484,"accession_number":"0001654954-25-001790","cik":1074828,"company_name":"USBC, Inc.","ticker":"USBC","form_type":"8-K","filed_at":"2025-02-21T23:59:59+00:00","items":["7.01","8.01","9.01"],"status":"ready","headline":"Know Labs cancels special meeting after implementing 1-for-40 reverse stock split","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Special meeting of stockholders scheduled for March 7, 2025 is canceled.","Board used Nevada law authority to effect a 1-for-40 reverse stock split without shareholder vote.","Reverse split became effective February 19, 2025; shares trade under temporary symbol KNWND on OTC Pink for 20 days.","Stockholder approval was unnecessary because authorized and outstanding shares were proportionally reduced."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":173030000.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":169483,"accession_number":"0001654954-25-001652","cik":1074828,"company_name":"USBC, Inc.","ticker":"USBC","form_type":"8-K","filed_at":"2025-02-18T23:59:59+00:00","items":["3.03","5.03","7.01","9.01"],"status":"ready","headline":"Know Labs effects 1-for-40 reverse stock split, trading moves to OTC Pink under KNWND","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Reverse split at 1:40 effective Feb 19, 2025; authorized shares cut from 300M to 7.5M.","Outstanding shares reduced from ~112.4M to ~2.8M; fractional shares rounded up to whole shares.","Ticker temporarily changes to KNWND for 20 days, then to KNWN on OTC Pink Market.","Split aims to regain NYSE American compliance after delisting proceedings started due to bid price under $0.10.","Company is appealing delisting to NYSE Listings Qualifications Panel; suspension during appeal."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":173030000.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":169482,"accession_number":"0001654954-25-001064","cik":1074828,"company_name":"USBC, Inc.","ticker":"USBC","form_type":"8-K","filed_at":"2025-02-03T23:59:59+00:00","items":["3.01","8.01","9.01"],"status":"ready","headline":"NYSE American commences delisting of Know Labs; stock moves to OTC Pink","summary_kind":"llm","event_type":"regulatory","confidence":"high","bullets":["NYSE Regulation suspended trading and initiated delisting due to bid price under $0.10.","Company has until February 5, 2025 to request a review by the Listings Qualifications Panel.","Effective January 30, 2025, stock trades on OTC Pink under symbol KNWN.","CEO states company is pursuing curative actions and will appeal the determination."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.9,"calibrated_materiality_score":0.9,"market_cap_usd":173030000.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":169481,"accession_number":"0001654954-25-000578","cik":1074828,"company_name":"USBC, Inc.","ticker":"USBC","form_type":"8-K","filed_at":"2025-01-21T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Know Labs forms licensing unit KTL to monetize RFDS IP across industries","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["New business unit KTL licenses Know Labs' radio frequency dielectric spectroscopy (RFDS) IP to corporate, academic partners.","Modeled after Qualcomm's QTL; will generate licensing revenue from industrial, auto, consumer electronics, IoT applications.","First focus is non-invasive blood glucose monitoring; also targeting a 'smart steering wheel' for automotive safety sensors.","Will provide SDKs and RFDS test automation tools to licensing partners; driven by unsolicited inbound demand."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":173030000.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":169480,"accession_number":"0001654954-24-016026","cik":1074828,"company_name":"USBC, Inc.","ticker":"USBC","form_type":"8-K","filed_at":"2025-01-02T23:59:59+00:00","items":["1.01","9.01"],"status":"ready","headline":"Know Labs enters ATM agreement with JonesTrading for up to $5M common stock offering","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Entered Capital on Demand Sales Agreement with JonesTrading Institutional Services LLC as sales agent.","May offer and sell up to $5,000,000 in common shares at prevailing market prices via at-the-market offering.","JonesTrading will receive up to 3.0% commission on gross proceeds; Company covers certain expenses.","Offering made under effective shelf registration statement (Form S-3) filed Dec 2023, effective Jan 2024.","No obligation to sell or buy any shares; JonesTrading acts on commercially reasonable efforts basis."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":173030000.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":186538,"accession_number":"0001654954-24-015708","cik":1074828,"company_name":"USBC, Inc.","ticker":"USBC","form_type":"8-K","filed_at":"2024-12-18T23:59:59+00:00","items":["1.01","9.01"],"status":"ready","headline":"Know Labs extends CEO's warrants for 5.77M shares at $0.25 to 2030","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Four warrants totaling 5,769,715 shares of common stock at $0.25 per share.","Expiration dates extended five years from 2025 to 2030 for all warrants.","Extension granted as consideration for Struve's agreement to extend promissory notes/debentures.","Board approved the amendment on December 17, 2024."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":173030000.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":186537,"accession_number":"0001654954-24-015707","cik":1074828,"company_name":"USBC, Inc.","ticker":"USBC","form_type":"8-K","filed_at":"2024-12-18T23:59:59+00:00","items":["1.01","9.01"],"status":"ready","headline":"Know Labs extends maturity of four convertible notes with Clayton Struve to Sept 2025","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Maturity date of notes dated Sep 30, 2016, Aug 14, 2017, Dec 12, 2017, and Feb 28, 2018 extended from Sep 30, 2024 to Sep 30, 2025.","Notes are senior secured and convertible, held by Clayton Struve.","No changes to interest rate, conversion terms, or other provisions disclosed in amendments."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"market_cap_usd":173030000.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":186536,"accession_number":"0001654954-24-015668","cik":1074828,"company_name":"USBC, Inc.","ticker":"USBC","form_type":"8-K","filed_at":"2024-12-18T23:59:59+00:00","items":["1.01","7.01","9.01"],"status":"ready","headline":"Know Labs raises $300K in registered direct offering of units at $0.24 per unit","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["1,250,000 units sold at $0.24/unit, each unit = one share + one warrant exercisable at $0.24 for 5 years.","Gross proceeds ~$300K before fees; net proceeds for KnowU glucose monitor development, clinical studies, and working capital.","Placement agent Boustead Securities receives 7% cash fee and a warrant for 87,500 shares at $0.24.","Warrants include cashless exercise option; offering priced at-the-market under NYSE American rules.","Offered via effective shelf registration S-3 (File 333-276246) and prospectus supplement filed December 13, 2024."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":173030000.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":186535,"accession_number":"0001654954-24-015377","cik":1074828,"company_name":"USBC, Inc.","ticker":"USBC","form_type":"8-K","filed_at":"2024-12-11T23:59:59+00:00","items":["3.01","8.01","9.01"],"status":"ready","headline":"Know Labs gets NYSE American nod on compliance plan; extension to Mar 2026","summary_kind":"llm","event_type":"regulatory","confidence":"high","bullets":["Stockholders' deficit of $4.6M as of June 30, 2024; losses in five most recent fiscal years.","NYSE American accepted plan to regain compliance with Sections 1003(a)(ii) and (iii) by March 27, 2026.","If insufficient progress or non-compliance by deadline, NYSE American may initiate delisting proceedings.","Company's common stock (KNW) continues trading on NYSE American during the plan period."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":173030000.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":186534,"accession_number":"0001654954-24-013513","cik":1074828,"company_name":"USBC, Inc.","ticker":"USBC","form_type":"8-K","filed_at":"2024-10-30T23:59:59+00:00","items":["5.02","5.07","5.03","9.01"],"status":"ready","headline":"Know Labs stockholders approve increase in authorized shares to 300M and equity plan shares to 40M","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Stockholders approved amendment to certificate of incorporation increasing authorized common shares from 200M to 300M.","Stockholders approved amendment to 2021 Equity Incentive Plan increasing authorized shares for issuance to 40M.","Votes: 57.5M for, 5.4M against on authorized shares increase; 19.7M for, 7.4M against on plan amendment (35.6M broker non-votes).","Amendment to articles filed with Nevada Secretary of State on October 29, 2024 and effective same date."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":173030000.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":186533,"accession_number":"0001654954-24-013353","cik":1074828,"company_name":"USBC, Inc.","ticker":"USBC","form_type":"8-K","filed_at":"2024-10-28T23:59:59+00:00","items":["1.01","9.01"],"status":"ready","headline":"Know Labs extends Erickson-affiliate convertible notes to Sep 2025; rate raised to 8%","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Two notes with J3E2A2Z LP, principal $519,833 and $664,233, extended to Sept 30, 2025.","Interest rate increased from 6% to 8%, effective retroactively to Sept 30, 2024.","Notes originally dated Jan 31, 2018; this is Amendment 11 for both notes.","Amendments approved Oct 22, 2024; Ronald P. Erickson is manager of holder and Chairman of Know Labs."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":173030000.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":186531,"accession_number":"0001654954-24-012815","cik":1074828,"company_name":"USBC, Inc.","ticker":"USBC","form_type":"8-K/A","filed_at":"2024-10-09T23:59:59+00:00","items":["8.01","5.07"],"status":"ready","headline":"Know Labs annual meeting results: all four proposals pass","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Seven director nominees elected with ~35.8M votes for, 352,777 withheld; 20.8M broker non-votes.","BPM LLP ratified as independent auditor for FY ending Sep 30, 2024: 56.7M for, 191,296 against.","Authorized issuance of shares underlying Lind convertible notes/warrants (exceeds 20% outstanding) with 34.3M for.","Non-binding advisory vote on executive compensation passed: 34.1M for, 1.4M against.","Turnout of 65.6% (56,964,556 shares voted) from 86,777,171 eligible shares."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"market_cap_usd":173030000.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":186532,"accession_number":"0001654954-24-012655","cik":1074828,"company_name":"USBC, Inc.","ticker":"USBC","form_type":"8-K","filed_at":"2024-10-02T23:59:59+00:00","items":["3.01","8.01","9.01"],"status":"ready","headline":"Know Labs receives NYSE American delisting notice for stockholders' equity deficiency","summary_kind":"llm","event_type":"regulatory","confidence":"high","bullets":["As of June 30, 2024, stockholders' deficit of $4.6M; losses in five most recent fiscal years triggered Sections 1003(a)(ii) and (iii).","Must submit a compliance plan by Oct 27, 2024; deadline to regain compliance by Mar 27, 2026.","Common stock continues trading under KNW with added “.BC” designation; no immediate impact on operations.","Plan will cite expected strategic partnerships and technological progress to support higher valuation and regain compliance."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":173030000.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":203113,"accession_number":"0001654954-24-012402","cik":1074828,"company_name":"USBC, Inc.","ticker":"USBC","form_type":"8-K","filed_at":"2024-09-27T23:59:59+00:00","items":["8.01"],"status":"ready","headline":"Know Labs shareholders elect seven directors and approve auditor, share issuance, and exec comp at annual meeting","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["All seven director nominees elected with ~35.8M shares for; 352.8K withheld and 20.8M broker non-votes.","Ratification of BPM LLP as auditor passed with 56.7M shares for, 191K against; no broker non-votes.","Authorization of shares underlying convertible notes/warrants to Lind Global Fund II approved with 34.3M shares for.","Non-binding advisory vote on named executive officer compensation approved with 34.05M shares for.","Turnout was 65.6% of eligible shares (56.96M proxies out of 86.78M)."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"market_cap_usd":173030000.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":203112,"accession_number":"0001654954-24-011759","cik":1074828,"company_name":"USBC, Inc.","ticker":"USBC","form_type":"8-K","filed_at":"2024-09-11T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Director Timothy Londergan resigns from Know Labs board; Ichiro Takesako appointed to audit committee","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Timothy Londergan resigned from the Board of Directors effective September 6, 2024.","Resignation was not due to any dispute or disagreement with the Company or Board.","Board appointed director Ichiro Takesako to fill the vacancy on the Company's Audit Committee."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":173030000.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":203111,"accession_number":"0001654954-24-010805","cik":1074828,"company_name":"USBC, Inc.","ticker":"USBC","form_type":"8-K","filed_at":"2024-08-16T23:59:59+00:00","items":["1.01","7.01","9.01"],"status":"ready","headline":"Know Labs raises $1.655M in registered direct offering of 6,365,385 units at $0.26/unit","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Each unit consists of one share common stock and one warrant to buy one share at $0.26.","Gross proceeds of $1.655M before expenses; offering closed August 15, 2024.","Proceeds to fund KnowU glucose monitor development, clinical studies, IP, and working capital.","Advisors Boustead Securities and Benchmark Company get 5% cash fee and warrants for 636,538 shares.","Shares and warrants issued under effective S-3 shelf registration statement (File No. 333-276246)."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":173030000.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":203110,"accession_number":"0001654954-24-010379","cik":1074828,"company_name":"USBC, Inc.","ticker":"USBC","form_type":"8-K","filed_at":"2024-08-13T23:59:59+00:00","items":["1.01","7.01","9.01"],"status":"ready","headline":"Know Labs raises $3.445M in underwritten public offering of 13.25M units at $0.26/unit","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Offering of 13,250,000 units, each consisting of one share of common stock and one warrant (exercise price $0.26).","Gross proceeds of $3.445M; underwriters' over-allotment partially exercised for 1,987,500 warrants.","Net proceeds to fund product development, clinical studies, IP, and working capital.","Offering closed on August 9, 2024; Benchmark and Boustead acted as joint book-runners.","Warrants exercisable at $0.26 per share; Representative options granted at same price."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":173030000.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":203109,"accession_number":"0001654954-24-008803","cik":1074828,"company_name":"USBC, Inc.","ticker":"USBC","form_type":"8-K","filed_at":"2024-07-11T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Know Labs publishes peer-reviewed study showing 93.37% accuracy in non-invasive glycemic status classification","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Study in Diabetes Technology & Therapeutics: RF sensor and ML algorithm classified glycemic status with 93.37% accuracy vs. venous blood glucose.","31 participants with prediabetes or Type 2 diabetes; 2,637 paired observations from OGTT and control sessions.","Sensitivities: 96.63% for normoglycemic, 85.51% for hyperglycemic; no misclassification between hypo- and hyperglycemic extremes.","CEO Ron Erickson: proof-of-concept for non-invasive screening device to help identify undiagnosed diabetes in underserved populations.","Company maintains focus on FDA-cleared non-invasive CGM (KnowU); RoW screening product explored with partners."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":173030000.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":239243,"accession_number":"0001654954-24-003437","cik":1074828,"company_name":"USBC, Inc.","ticker":"USBC","form_type":"8-K","filed_at":"2024-03-20T23:59:59+00:00","items":["1.01","9.01"],"status":"ready","headline":"Know Labs enters $5M at-the-market offering agreement with Benchmark","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["ATM agreement with Benchmark Company allows sale of up to $5M of common stock at prevailing market prices.","Benchmark receives 3.5% commission on gross proceeds; company reimburses certain expenses.","Sales may occur from time to time until all shares sold or agreement terminated; no obligation to sell.","Offers are made under effective shelf registration statement (333-276246) filed Dec 2023."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":173030000.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":239242,"accession_number":"0001654954-24-002728","cik":1074828,"company_name":"USBC, Inc.","ticker":"USBC","form_type":"8-K","filed_at":"2024-03-06T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Know Labs’ RF glucose sensor achieves 11.1% MARD in first venous-blood study","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Overall MARD of 11.1±2.1% in test dataset; similar accuracy in normoglycemic (11.0%) and hyperglycemic (11.5%) ranges.","First study using venous blood as reference in participants with prediabetes and Type 2 diabetes.","Study involved 21 three-hour sessions with 75g OGTT; 520 paired values for training, 130 for test.","Clinical trial completed (up to 100 participants, Sep 2023–Feb 2024); company plans large-scale external trials in 2024.","Dr. Virend K. Somers of Mayo Clinic is co-investigator; results presented at ATTD conference in Florence."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":173030000.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":239238,"accession_number":"0001654954-24-002730","cik":1074828,"company_name":"USBC, Inc.","ticker":"USBC","form_type":"8-K/A","filed_at":"2024-03-06T23:59:59+00:00","items":["1.01","2.03","3.02","8.01","9.01"],"status":"ready","headline":"Know Labs corrects warrant count to 6M shares in $14.4M convertible note facility with Lind","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Initial $4.8M senior convertible note (0% interest) for $4M purchase price; conversion at $1.00/share.","Warrants to purchase up to 6M shares at $0.80/share; cashless exercise allowed if registration ineffective.","Monthly payments start 120 days after issuance: greater of 5% principal or $240k; paid in cash, stock, or both.","Placement agent Benchmark receives $200k cash fee and 102,302 unregistered shares.","Notes secured by first-priority lien on all assets; subsidiary Particle guarantees obligations."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":173030000.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":239241,"accession_number":"0001654954-24-002413","cik":1074828,"company_name":"USBC, Inc.","ticker":"USBC","form_type":"8-K","filed_at":"2024-02-29T23:59:59+00:00","items":["1.01","2.03","3.02","8.01","9.01"],"status":"ready","headline":"Know Labs secures up to $12M in convertible note funding from Lind Global Fund II","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Initial close: $4M cash for a $4.8M face-value convertible note; conversion price $1.00/share (50% premium to $0.667 close).","Warrant to purchase 3M shares at $0.80/share (20% premium), exercisable for 60 months starting 6 months post-funding.","Monthly repayments begin 120 days after funding; can be in cash (plus 5% premium) or stock at 90% of 3-lowest VWAP average.","Notes secured by all company assets; include default triggers such as market cap below $15M for 10 consecutive days.","Company to file resale registration statement for underlying shares within 30 days, seek effectiveness within 90 days."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":173030000.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":239240,"accession_number":"0001654954-24-002222","cik":1074828,"company_name":"USBC, Inc.","ticker":"USBC","form_type":"8-K","filed_at":"2024-02-27T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Know Labs announces KnowU wearable non-invasive CGM with FDA-submission sensor","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["KnowU integrates proprietary RF sensor intended for FDA clearance, tested stable and accurate in lab.","Device is smaller and lighter than June 2023 prototype, with on-board computing and machine learning.","Wearable via adhesive or strap; features rechargeable battery and companion mobile app.","Company plans to deploy KnowU in large-scale clinical trials in 2024 while refining algorithms."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":173030000.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":239239,"accession_number":"0001654954-24-001788","cik":1074828,"company_name":"USBC, Inc.","ticker":"USBC","form_type":"8-K","filed_at":"2024-02-14T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Know Labs Q1 net loss $3.45M, EPS -$0.04; cash burn $3.39M; going concern remains","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net loss $3.45M vs $3.82M year ago; EPS loss -$0.04 improved from -$0.08.","R&D expense $1.48M, down 14.7% YoY; SG&A $2.01M, up 5.6% YoY.","Cash $4.82M at Dec 31, down from $8.02M at Sep 30; operating burn $3.39M in Q1.","Filed $18M S-3 shelf registration, effective Jan 11, 2024, for future fundraising.","Going concern qualification; management says cash sufficient until June 30, 2024."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.04,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":"2025-Q1","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":173030000.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":256747,"accession_number":"0001654954-23-015501","cik":1074828,"company_name":"USBC, Inc.","ticker":"USBC","form_type":"8-K","filed_at":"2023-12-14T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Know Labs Adds Four New Members to Medical and Scientific Advisory Board","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Jeff Hitchcock, founder of Children with Diabetes, appointed to board.","Karmeen Kulkarni, former Director of Global Scientific Affairs at Abbott Diabetes Care, appointed.","Dr. Meng Tan, Professor Emeritus at University of Michigan and former Lilly executive, appointed.","Dr. Satish Garg, Professor at Barbara Davis Center and Editor-in-Chief of Diabetes Technology & Therapeutics, appointed."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":173030000.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null}],"next_cursor":"2023-12-14T23:59:59+00:00|256747"}